XML 50 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Noncontrolling Interest (Details Textual) - USD ($)
3 Months Ended 6 Months Ended
Dec. 30, 2015
Dec. 17, 2012
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Consulting Services, Monthly Payment $ 23,438          
Consulting Services, Period of Services 4 years          
Net Income (Loss) Attributable to Noncontrolling Interest     $ (173,911) $ (54,859) $ (237,167) $ (121,831)
Revenue, Net     99,978 $ 38,986 145,995 $ 52,928
Clyra Medical Technology Inc [Member]            
Sale of Stock, Percentage of Ownership after Transaction 54.00%          
Clyra Medical Technology Inc [Member]            
Investment Owned, Balance, Shares   7,500        
Preferred Stock, Dividend Rate, Percentage 8.00%          
Preferred Shares Dividend, Period 5 years          
Dividends Payable     90,000   90,000  
Net Income (Loss) Attributable to Noncontrolling Interest     (387,490)   (524,572)  
Revenue, Net     $ 0   $ 0  
Clyra Medical Technology Inc [Member] | Series A Preferred Stock [Member] | Sanatio [Member]            
Sale of Stock, Number of Shares Issued in Transaction 9,830          
Proceeds from Issuance or Sale of Equity $ 750,000          
Clyra Medical Technology Inc [Member] | Each of 3 Individuals [Member]            
Stock Issued During Period, Shares, New Issues   1,500        
Sanatio [Member] | Clyra Medical Technology Inc [Member]            
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 40.00%